Your browser doesn't support javascript.
loading
Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel.
Yuen, F; Wu, S; Thirumalai, A; Swerdloff, R S; Page, S T; Liu, P Y; Dart, C; Wu, H; Blithe, D L; Sitruk-Ware, R; Long, J; Bai, F; Hull, L; Bremner, W J; Anawalt, B D; Wang, C.
Afiliação
  • Yuen F; Department of Medicine, Division of Endocrinology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Wu S; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Thirumalai A; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Swerdloff RS; Department of Medicine, Division of Endocrinology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Page ST; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Liu PY; Department of Medicine, Division of Endocrinology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Dart C; Health Decisions, Durham, NC, USA.
  • Wu H; Health Decisions, Durham, NC, USA.
  • Blithe DL; Contraceptive Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Sitruk-Ware R; Center for Biomedical Research, Population Council, New York, NY, USA.
  • Long J; Contraceptive Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Bai F; Department of Medicine, Division of Endocrinology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Hull L; Department of Medicine, Division of Endocrinology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Bremner WJ; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Anawalt BD; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Wang C; Department of Medicine, Division of Endocrinology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
Andrology ; 7(2): 235-243, 2019 03.
Article em En | MEDLINE | ID: mdl-30556332
ABSTRACT

BACKGROUND:

Testosterone (T)/Nestorone (NES) combination gel is a potential transdermal male contraceptive that suppresses gonadotropins and spermatogenesis. Transfer of transdermal T from men to women can be prevented by washing or covering application sites with clothing.

OBJECTIVES:

We hypothesized that showering or wearing a shirt over gel application sites would prevent secondary exposure of T and NES to a woman after close skin contact. MATERIALS AND

METHODS:

Twelve healthy male and 12 healthy female participants were recruited. Men applied T/NES 62 mg/8 mg gel to their shoulders and upper arms. Two hours after application, female partners rubbed the application site for 15 min. Exposure in the female partner was assessed under three conditions a shirt covered the application site; the man showered prior to skin contact; or without intervention to reduce transfer. Serum T and NES concentrations were measured by LC-MS/MS in serial blood samples for 24 h after gel exposure. MAIN

OUTCOMES:

Change in female serum T and NES levels as measured by average concentration over 24 h (Cavg ).

RESULTS:

Median female serum T Cavg was 23.9 ng/dL (interquartile range, 19.3, 33.9) with the shirt barrier and 26.7 ng/dL (20.7, 33.9) after showering, which was higher than baseline 20.9 ng/dL (16.7, 25.0), both p < 0.03) but lower than without intervention (58.2 ng/dL [30.9, 89.1], both p < 0.01). Female serum NES Cavg and maximum concentration were below the lower limit of quantification with the shirt barrier and after showering, but increased without intervention in six of 12 women (maximum concentration <60 pg/mL). Men had lower average serum NES levels after showering (47 pg/ml [20, 94] compared to no intervention (153.3 pg/mL [51, 241], p < 0.02).

CONCLUSION:

Secondary transfer of T and NES occurs after intensive skin contact with the gel application site. Secondary transfer is decreased by a shirt barrier or showering before contact.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testosterona / Anticoncepcionais Masculinos / Norprogesteronas Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testosterona / Anticoncepcionais Masculinos / Norprogesteronas Idioma: En Ano de publicação: 2019 Tipo de documento: Article